Clinical Trials Directory

Trials / Completed

CompletedNCT04721314

Personalized Pacing: A New Paradigm for Patients With Diastolic Dysfunction or Heart Failure With Preserved Ejection Fraction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
123 (actual)
Sponsor
University of Vermont · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Recent exploratory studies suggest that pacemaker patients with diastolic dysfunction (DD) or heart failure with preserved ejection fraction (HFpEF) may benefit from a higher backup heart rate (HR) setting than the factory setting of 60 beats per minute (bpm). In this prospective double-blinded randomized controlled study, pacemaker patients with DD or overt HFpEF and either 1) intrinsic ventricular conduction or 2) conduction system or biventricular pacing will be enrolled and randomized to either a personalized lower HR setting (myPACE group, based on a height-based HR algorithm) or to the standard 60bpm backup setting (control group) for 1 year.

Conditions

Interventions

TypeNameDescription
DEVICEAdjustment of lower rate limitPatients with preserved ejection fraction (EF \>50%) and implanted pacemakers will have the lower rate limit adjusted to a personalized heart rate based on a heart rate algorithm.
DEVICEMaintenance of lower rate limitLower rate limit will be maintained at 60 beats-per-minute

Timeline

Start date
2019-07-17
Primary completion
2021-10-30
Completion
2021-12-05
First posted
2021-01-22
Last updated
2022-02-09

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04721314. Inclusion in this directory is not an endorsement.